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Prostaglandins (PGs) play important roles in the regulation of cutaneous cell functions under physiological and
pathological conditions. In this study, we examined the involvement of PGs in sebocyte lipogenesis using non-
steroidal anti-inﬂammatory drugs in vivo and in vitro. Hamster auricle sebocytes spontaneously differentiated to
accumulate intracellular triacylglycerol (TG), under which the relative levels of 15-deoxy-D12,14-PGJ2 (15d-PGJ2) to
PGF2a and PGE2 increased. 15d-PGJ2 was found to augment the formation of lipid droplets, which was because of
an increase of TG synthesis by diacylglycerol acyltransferase (DGAT). Furthermore, sebocytes constitutively pro-
duced cyclooxygenase 2 (COX-2), but not COX-1, in vivo and in vitro. When sebocytes were treated with COX
inhibitors such as indomethacin, diclofenac, or NS-398, the production of PGF2a and PGE2 decreased. The pro-
duction of 15d-PGJ2, however, was increased in these inhibitor-treated sebocytes. In addition, indomethacin,
diclofenac, and NS-398 augmented the synthesis of TG along with the increase in DGAT activity. Similarly, topical
administration of indomethacin to hamster auricles caused the development of sebaceous glands with the aug-
mentation of sebum deposition in vivo. Furthermore, indomethacin and NS-398-augmented 15d-PGJ2 production
and TG synthesis were suppressed by a non-selective cytochrome P-450 (CYP) inhibitor, SKF-525A. A ligand
activator of peroxisome proliferation activating receptor c (PPARc), troglitazone-induced synthesis of TG, however,
was not altered even in the presence of SKF-525A. These results suggest that 15d-PGJ2 is a crucial stimulator of
sebocyte lipogenesis by augmenting DGAT-mediated synthesis of TG. In addition to the COX-2-dependent pathway
of PG synthesis, our ﬁndings suggest a sebocyte-specific pathway of 15d-PGJ2 production by CYP, the activity of
which may be evoked by inhibiting COX-2.
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By secreting sebum, sebaceous glands participate in the
formation of a thin lipid layer on the skin surface as a phys-
iological barrier (Thody and Shuster, 1989; Fluhr et al, 2003).
Sebaceous gland cells (sebocytes) differentiate to accumu-
late abundant cytoplasmic lipids, and, using a holocrine
mechanism, lead to the secretion of lipids as sebum
(Sawaya et al, 1988; Akamatsu et al, 1992; Zouboulis
et al, 1994; Rosenfield et al, 1998). An excess secretion of
sebum causes sebaceous-gland disorders such as acne
vulgaris and seborrhea, which are the most common skin
diseases (Harris et al, 1983; Pie´rard et al, 1987; Zouboulis
et al, 1998).
Recently, in vitro cultures of sebocytes have been es-
tablished from sebaceous glands of humans (Xia et al, 1989;
Fujie et al, 1996; Zouboulis et al, 1999; Thiboutot et al, 2003)
and rats (Laurent et al, 1992). Plewig and Luderschmidt
(1977) reported that hamster sebaceous glands are similar
to human glands with regard to size, response to andro-
gens, and turnover time. Ito et al (1998) described a culture
method for hamster sebocytes from the auricles, and dem-
onstrated that the proliferation of hamster sebocytes in re-
sponse to androgens is similar to that of human sebocytes.
Therefore, like human sebocytes, the cultured hamster se-
bocytes are a useful tool for studying the functions of se-
baceous glands in vitro.
These in vitro cell culture models have stimulated the
elucidation of cellular properties of sebocytes, and studies
on the pathological and physiological regulation of sebum
synthesis by hormones (Xia et al, 1989; Rosenfield et al,
1998; Zouboulis et al, 1999; Thiboutot et al, 2003). Sebum
secretion and synthesis have been reported to be aug-
mented by androgens such as testosterone and 5a-dihyd-
rotestosterone (Akamatsu et al, 1992; Zouboulis et al, 1994;
Rosenfield et al, 1998; Sato et al, 2001a), and by insulin
(Deplewski and Rosenfield, 1999) in humans, rats, and
hamsters. In contrast, estrogen (Ebling and Skinner, 1983)
and all-trans and 13-cis retinoic acids (Hommel et al, 1996;
Orfanos and Zouboulis, 1998; Zouboulis et al, 1999; Sato
et al, 2001a) have been reported to suppress the formation
of intracellular lipid droplets in vivo and in vitro. We reported1The first two authors contributed equally to this work.
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that epidermal growth factor (EGF), basic fibroblast growth
factor, transforming growth factor-a, keratinocyte growth
factor, and 1a,25-dihydroxyvitamin D3 suppress lipogenesis
in hamster sebocytes (Sato et al, 2001a; Akimoto et al,
2002).
Prostaglandins (PGs) play important roles in the regula-
tion of cellular functions under physiological and patho-
logical conditions. Cyclooxygenase (COX)/prostaglandin
endoperoxide H synthase, two types of which, COX-1 and
COX-2, have been characterized in mammalians, is a rate-
limiting enzyme complex for the production of PGs (Hruza
and Pentland, 1993; Narumiya et al, 1999; Tiano et al, 2002).
It has been reported that PGE2 participates in epidermal
repair such as wound healing by its regulation of prolifer-
ation and differentiation of keratinocytes (Pentland and
Needleman, 1986; Unemori et al, 1994; Sato et al, 1997).
Sebocytes are classified as epithelial cells, and morpho-
logically and functionally differentiate to form intracellular
lipid droplets (Rosenfield et al, 1998; Deplewski and
Rosenfield, 1999). Therefore, it seems that, like keratin-
ocytes, PGs may participate in the regulation of biological
functions of sebaceous glands. It remains unclear, however,
whether PGs are associated with the development of se-
baceous glands and sebocyte lipogenesis.
In this study, we investigated the possible involvement of
PGs in the formation of intracellular lipid droplets in hamster
sebaceous glands in vivo and in vitro. Our findings show
that 15-deoxy-D12,14-PGJ2 (15d-PGJ2) plays a crucial role in
the augmentation of lipid-droplet formation by increasing
triacylglycerol (TG) synthesis in hamster sebocytes, and that
the synthesis of 15d-PGJ2 is mediated by COX-2 and cyto-
chrome P-450 (CYP)-dependent pathways.
Results
15d-PGJ2 stimulates the differentiation of sebocytes
with increasing intracellular levels of TG We first exam-
ined the relationship between PG levels and lipogenesis
during the differentiation of hamster sebocytes. As intracel-
lular lipid droplets accumulate in sebocytes mostly consist
of TG (Sato et al, 2001a), we evaluated sebocytic differen-
tiation by measuring intracellular levels of TG. As shown in
Fig 1A, levels of TG (closed squares) were found to increase
in cell culture time dependently . The level of PGF2a (open
squares) was somewhat higher than that of PGE2 (open tri-
angles) and 15d-PGJ2 (open circles) on day 3 in culture, but
was found to decrease time dependently for up to 12 d (to
o10 pg per mg DNA). The level of PGE2 was considerably
lower (o10 pg per mg DNA). 15d-PGJ2 levels were aug-
mented for 6 d and this augmented level (20–30 pg per mg
DNA) was sustained for up to 12 d, indicating that 15d-PGJ2
is predominant in differentiated hamster sebocytes. It was
found that hamster sebocytes constitutively produce COX-2
with the same molecular weight as the human COX-2 pro-
tein and its production slightly decreased for up to 12 d (Fig
1B, lower panel). Furthermore, COX-2 was found to be ex-
pressed in sebaceous glands (see SG, Fig 1B, lower panel).
There was no detectable COX-1 in either sebaceous glands
or cultured sebocytes (see Fig 1B, upper panel).
To clarify whether 15d-PGJ2 might induce the differen-
tiation of sebocytes, we investigated the effect of ex-
ogenous 15d-PGJ2 on the formation of lipid droplets in
hamster sebocytes. When 15d-PGJ2 (1–10 mM) was added
in the sebocyte culture, the formation of intracellular lipid
droplets (Fig 2B vs A) and TG levels (Fig 2C) increased in a
concentration-dependent manner. As shown in Table I, 15d-
PGJ2-induced augmentation of TG production was found to
be associated with an increase in the activity of diacylglyc-
erol acyltransferase (DGAT), a rate-limiting enzyme of TG
synthesis (po0.001).
Effects of COX inhibitors on the production of PGs in
hamster sebocytes To clarify the possible involvement of
15d-PGJ2 in increasing sebocyte lipogenesis, we investi-
gated the effects of COX inhibitors on the production of TG
and the formation of intracellular lipid droplets in cultured
hamster sebocytes. As shown in Fig 3, levels of PGE2 (panel
A) and PGF2a (panel B) were significantly diminished
(po0.001) by non-selective COX inhibitors, indomethacin
(10 mM) and diclofenac (10 mM), and by a COX-2-specific
inhibitor, NS-398 (20 mM). The level of 15d-PGJ2 in the me-
dium was found to increase in sebocytes treated with in-
domethacin (po0.01), diclofenac (po0.01), and NS-398
(po0.001) (Fig 3C). In contrast, there was no change in
the level of PGD2 between untreated and indomethacin (10
Figure1
Levels of prostaglandins (PG) during sebocyte differentiation in
vitro. Hamster sebocytes at the 2nd passage were cultured for 12 d,
with replacement of fresh culture medium every 3 d. (A) The harvested
culture medium at each indicated period was subjected to measure-
ment of PGE2 (open triangles), PGF2a (open squares), and 15-deoxy-
D12,14-PGJ2 (15d-PGJ2) (open circles). Levels of intracellular triacyl-
glycerol (TG) (closed squares) were time dependently augmented dur-
ing cell culture. Data are shown as mean  standard deviation of
triplicate dishes. (B) The harvested cells at each indicated period and
sebaceous glands (SG) were subjected to western blot analysis for
cyclooxygenase (COX)-1 and COX-2. St indicates human COX-1 (upper
panel) and COX-2 (lower panel). Three independent experiments were
reproducible, and typical data are shown.
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mM)-treated sebocytes (0.49  0.06 vs 0.54  0.09 pg per
mg DNA, respectively). Neither COX-1 nor COX-2 produc-
tion was altered in the COX inhibitor-treated cells (see Fig
S1). Moreover, in primarily cultured hamster skin fibroblasts,
these three inhibitors were found to inhibit the production of
PGE2, PGF2a, and 15d-PGJ2 (data not shown).
Augmentation of lipogenesis and development of seba-
ceous glands by COX inhibitors Because of our finding
that 15d-PGJ2 production was increased in sebocytes even
when COX inhibitors were present, we examined whether
the inhibitors could augment lipogenesis in sebaceous
glands. As shown in Fig 4, the production of TG was found
to increase concentration dependently in the presence of
indomethacin (1–10 mM), diclofenac (0.1–10 mM), and NS-
398 (5–20 mM). The formation of intracellular lipid droplets
also increased (data not shown). There were no significant
changes in the levels of free fatty acids and cholesterol
compared with those of TG in the lipids (data not shown).
The selective augmentation of TG production by indo-
methacin, diclofenac, and NS-398 was found to be asso-
ciated with an increase in DGAT activity in hamster
sebocytes (Table I). When auricles from 5-wk-old male
golden hamsters were topically treated with 2% (wt/vol)
Figure 2
Exogenous 15-deoxy-D12,14-PGJ2 (15d-PGJ2) augments the forma-
tion of lipid droplets by increasing intracellular levels of triacyl-
glycerol (TG) in hamster sebocytes. Oil-red-O staining of cultured
hamster sebocytes at the 2nd passage shows that the accumulation of
lipid droplets is spontaneously observed in untreated cells (A) and
augmented by addition of 15d-PGJ2 (10 mM) for 12 d (B). Intracellular
levels of TG (C) also increase in a concentration-dependent manner
using 15d-PGJ2 (1–10 mM). Four independent experiments were re-
producible, and typical data are shown. Data are shown as
mean  standard deviation of triplicate dishes. , , and  indicate
results that were significantly different from untreated control cells
(Cont) at p levels of o0.05, o0.01, and o0.001, respectively. Mag-
nifications in panels A and B:  200.
Table I. Increase of DGAT activity by 15d-PGJ2 and COX
inhibitors in hamster sebocytes
Treatments lM
DGAT activity (pmol
per min per lg DNA)
None — 564.4  14.6
15d-PGJ2 10 961.7  18.1a
Indomethacin 10 1142.0  36.9a
Diclofenac 10 1120.3  39.5a
NS-398 20 869.7  63.2a
apo0.001, between untreated and COX inhibitors or 15d-PGJ2-treated
cells.




Regulation of prostaglandin (PG) production by cyclooxygenase
(COX) inhibitors in hamster sebocytes. Hamster sebocytes at the
2nd passage were treated every 3 d with indomethacin (Ind) (10 mM),
diclofenac (Dic) (10 mM), and NS-398 (NS) (20 mM) for 12 d. Culture
media were harvested at 12 d and subjected to measurement of PGE2
(A), PGF2a (B), and 15-deoxy-D
12,14-PGJ2 (15d-PGJ2) (C). Four inde-
pendent experiments were reproducible, and typical data are shown.
Data are shown as mean  standard deviation of triplicate dishes. 
and  indicate significant differences from untreated control cells
(Cont) with p values of o0.01 and o0.001, respectively.
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indomethacin for 14 d, the development of sebaceous
glands (arrow heads) with the deposition of sebum (aster-
isks) was observed (Fig 5B vs A).
Involvement of a novel CYP-mediated pathway of 15d-
PGJ2 synthesis in sebocyte lipogenesis Based on our
finding that indomethacin, diclofenac, and NS-398 cause
the selective augmentation of 15d-PGJ2 production in ham-
ster sebocytes, a COX-independent pathway may be
involved in the increase of 15d-PGJ2 production. As it has
been reported that arachidonic acid is metabolized not only
by COX but also by CYP (Laniado-Schwartzman et al, 1988;
Capdevila et al, 2000), we investigated the effect of a CYP
inhibitor on the production of 15d-PGJ2 and on the synthe-
sis of intracellular TG in COX inhibitor-treated sebocytes. As
shown in Fig 6A, a non-selective CYP inhibitor, SKF-525A
(10 and 20 mM), suppressed indomethacin and NS-398-
induced production of 15d-PGJ2. These COX inhibitor-
augmented levels of intracellular TG were diminished by
SKF-525A (Fig 6B). SKF-525A did not influence the basal
levels of 15d-PGJ2 and TG in hamster sebocytes (Fig 6).
Figure 4
Effects of cyclooxygenase (COX) inhibitors on levels of triacyl-
glycerol (TG) in hamster sebocytes. Intracellular levels of TG were
concentration-dependently augmented in indomethacin (1–10 mM)-,
diclofenac (0.1–10 mM)-, and NS-398 (5–20 mM)-treated hamster se-
bocytes at the 2nd passage. Four independent experiments were
reproducible and typical data are shown. Data are shown as
mean  standard deviation of triplicate dishes. , , and  indicate
significant differences from untreated control cells (Cont) with p values
of o0.05, o0.01, and o0.001, respectively.
Figure 5
Development of sebaceous glands by topically administering in-
domethacin in vivo. Histochemical staining of hamster auricles shows
that topical treatment of indomethacin for 2 wk (B) leads to the devel-
opment of sebaceous glands (arrow heads), and augments the dep-
osition of sebum (asterisks) compared with vehicle-treated auricles (A).
Three independent experiments were reproducible, and typical data are
shown. Scale bar, 300 mm.
Figure6
A cytochrome P-450 (CYP) inhibitor suppresses indomethacin- and
NS-398-augmented production of 15-deoxy-D12,14-PGJ2 (15d-PGJ2)
and triacylglycerol (TG) in hamster sebocytes. Hamster sebocytes at
the 2nd passage were treated with indomethacin (Ind) (10 mM) and NS-
398 (NS) (20 mM) in the presence of SKF-525A (10 and 20 mM) for 12 d.
Culture media and cells harvested at 12 d were subjected to meas-
urement of 15d-PGJ2 (A) and intracellular TG (B). Three independent
experiments were reproducible, and typical data are shown. Data are
shown as mean  standard deviation of triplicate dishes. a, b, and c
indicate significant differences from untreated control cells (Cont) with
p values of o0.05, o0.01, and o0.001, respectively. , , and 
indicate significant differences from indomethacin (Indo) alone with p
values of o0.05, o0.01, and o0.001, respectively. ### indicates sig-
nificant differences from NS-398 (NS) alone with p values of o0.001.
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Similar results were obtained when another non-selective
CYP inhibitor, methoxsalen, was used (data not shown). As
it has been reported that 15d-PGJ2 as well as PGJ2 is an
endogenous activator of peroxisome proliferation-activating
receptor g (PPARg) (Kliewer et al, 1995; Yu et al, 1995;
Shibata et al, 2002; Scher and Pillinger, 2005), and that the
activation of PPARg1 in sebocytes causes an increase in
lipogenesis (Rosenfield et al, 1999), we examined the effect
of SKF-525A on the synthesis of TG in hamster sebocytes
treated with a ligand activator of PPARg, troglitazone. As
shown in Table II, troglitazone-augmented TG synthesis was
not influenced by SKF-525A (5–20 mM).
Discussion
The proliferation and differentiation of keratinocytes have
been reported to be regulated by PGE2, which may be
associated with the development of the epidermis and
epidermal repair under wound healing (Pentland and
Needleman, 1986; Unemori et al, 1994; Sato et al, 1997).
Sebocytes are classified as epithelial cells, and cause ter-
minal differentiation with the intracellular accumulation of
lipids (Rosenfield et al, 1998; Deplewski and Rosenfield,
1999), it seems that PG might be involved in the regulation
of sebaceous development and functions. In this study, the
basal level of 15d-PGJ2 was found to increase, whereas
that of PGF2a decreased and that of PGE2 did not change
during spontaneous differentiation of hamster sebocytes in
vitro. We demonstrated that the formation of intracellular
lipid droplets was augmented by exogenously administering
15d-PGJ2, and was associated with an increase in DGAT-
mediated TG biosynthesis in hamster sebocytes. Neufang
et al (2001) reported that the development of sebaceous
glands with sebum deposition is augmented in transgenic
mice overexpressing COX-2 in the epidermis, in which the
levels of PGF2a and PGE2 are elevated. But, they did not
show data for 15d-PGJ2 in their transgenic mice. As a COX-
mediated arachidonic acid metabolite, PGH2, is a common
precursor for 15d-PGJ2, PGF2a, and PGE2 (Narumiya et al,
1999; Tiano et al, 2002; Helliwell et al, 2004; Scher and
Pillinger, 2005), it is assumed that levels of not only PGF2a
and PGE2 but also 15d-PGJ2 are augmented in the epider-
mis in the transgenic mice. Taken together, these findings
suggest that the increase in levels of 15d-PGJ2 rather than
PGF2a and PGE2 could cause augmentation of lipogenesis
in sebaceous glands.
Non-steroidal anti-inflammatory drugs such as indo-
methacin and diclofenac have been useful in elucidating
the involvement of PG in pathological and physiological re-
actions in vivo and in vitro by their inhibition of COX activity
(Kobayashi et al, 1985; Smith et al, 1998). In this study, we
demonstrated that hamster sebocytes express COX-2
constitutively, but not COX-1, and that indomethacin, di-
clofenac, and NS-398 inhibit the production of PGE2 and
PGF2a in sebocytes, which is dependent on a COX-2 path-
way. Unexpectedly, however, there was no change in the
level of PGD2 in indomethacin-treated sebocytes. Further-
more, the treatment of hamster sebocytes with indo-
methacin, diclofenac, and NS-398 caused an increase in
15d-PGJ2 production, suggesting that the production of
PGD2 and 15d-PGJ2 in hamster sebocytes is regulated by
the COX-independent pathway. In accord with the aug-
mentation of 15d-PGJ2 production, the formation of intra-
cellular lipid droplets and of DGAT-mediated biosynthesis of
TG was found to be increased in these COX inhibitor-treat-
ed sebocytes. Topical administration of indomethacin to
auricles of male golden hamsters resulted in the develop-
ment of sebaceous glands and the enhancement of sebum
accumulation in vivo. These findings strongly suggested
that hamster sebocytes possess at least two mechanisms
for the biosynthesis of PG: (i) a general COX-2-dependent
pathway for prostanoid synthesis (Narumiya et al, 1999;
Tiano et al, 2002) and (ii) a novel pathway for 15d-PGJ2
synthesis, which may be stimulated by inhibiting COX-2
activity (Fig 7).
Regarding COX-independent PG production, it has been
reported that CYP participates in arachidonic acid metab-
olism (Laniado-Schwartzman et al, 1988; Capdevila et al,
2000). Keeney et al (1998) reported that CYP2B12 is spe-
cifically expressed in rat sebaceous glands. Thiboutot et al
Table II. No effect of CYP inhibitor on troglitazone-augmented
TG synthesis in hamster sebocytes
Treatments lM
Levels of TG
(lg per lg DNA)
None — 0.74  0.24
Troglitazone 10 2.37  0.17a
TroglitazoneþSKF-525A 5 2.13  0.22
10 2.51  0.30
20 2.13  0.14
apo0.001, between untreated and troglitazone-treated cells.
CYP, cytochrome P-450; TG, triacylglycerol.
Figure7
A possible mechanism for sebocyte lipogenesis through a cyto-
chrome P-450-15-deoxy-D12,14-PGJ2-peroxisome proliferation
activating receptor c1 (CYP-15d-PGJ2-PPARc1) pathway. Cycloox-
ygenase (COX)-2-dependent and -independent pathways of 15d-PGJ2
production are present in hamster sebocytes. Although the basal pro-
duction of PGs is mediated by a COX-2-dependent pathway, the in-
hibition of COX-2 activity by non-steroidal anti-inflammatory drugs
(NSAIDs) specifically leads to an increase in 15d-PGJ2 production
though a CYP-mediated pathway. The basal and the CYP-mediated
augmentation of 15d-PGJ2 production result in an increase of diacyl-
glycerol acyltransferase (DGAT)-mediated production of TG through
PPARg1 activation.
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(2003) reported that CYP11A and CYP17 are expressed in
sebaceous glands and ducts of human facial skin. In this
study, our finding that SKF-525A suppressed indomethacin
and NS-398-induced production of 15d-PGJ2 and TG sug-
gests that there is a novel CYP-mediated pathway for the
synthesis of 15d-PGJ2 in hamster sebaceous glands, which
may be activated by inhibiting COX-2 activity (Fig 7). There
was no change in the basal level of 15d-PGJ2 in sebocytes
treated with CYP inhibitor alone. Taken together with data
for hamster sebocytes that constitutively produce COX-2
in vivo and in vitro, these results suggest the possibility that
the basal level of 15d-PGJ2 may be produced through a
COX-2-dependent pathway (Fig 7). Further experiments will
be needed to identify the subtype of CYP in hamster se-
bocytes, and to clarify the mechanism for the production of
15d-PGJ2 through COX-2- and CYP-dependent pathways
during the synthesis of sebum in sebaceous glands.
15d-PGJ2 is an endogenous activator of PPARg for lipo-
genesis in adipocytes (Kliewer et al, 1995; Yu et al, 1995;
Shibata et al, 2002; Scher and Pillinger, 2005). Rosenfield
et al (1999) reported the involvement of PPARg1 in the aug-
mentation of lipogenesis in rat sebocytes. We also demon-
strated that hamster sebocytes constitutively express
PPARa and g1 in vitro, whose activation by ligand activa-
tors for PPARa and g augments the formation of lipid drop-
lets and the production of TG (Akimoto et al, 2005).
Therefore, it is likely that the elevated levels of 15d-PGJ2
cause the activation of PPARg1, which in turn augments the
synthesis of TG in hamster sebocytes. Moreover, we found
that PPARg1-mediated augmentation of DGAT-dependent
production of TG is not influenced by SKF-525A. This sug-
gests that the CYP-mediated augmentation of 15d-PGJ2
production may occur upstream of the PPARg1 pathway in
sebocyte lipogenesis (Fig 7).
In conclusion, we suggest that 15d-PGJ2 is a crucial
stimulator of sebocyte lipogenesis by augmenting DGAT-
mediated synthesis of TG or by decreasing the activity of
TG lipase (Dolinsky et al, 2004). In addition to the COX-2
pathway, we suggest a CYP-mediated sebocyte-specific
pathway for 15d-PGJ2 synthesis, the activity of which may
be evoked by selectively inhibiting COX-2 (Fig 7). Finally,
these findings should provide an increased understanding
of the functions of sebaceous glands in normal and dis-
eased skin, and could contribute to the development of
drugs and clinical strategies for skin diseases such as acne
vulgaris.
Materials and Methods
Cell culture and treatments Hamster sebocytes were established
from sebaceous glands of auricles of 5-wk-old male golden ham-
sters as described previously (Ito et al, 1998; Sato et al, 2001a).
Sebocytes (2.35  104 cells per cm2) in Dulbecco’s modified Ea-
gle’s medium/Ham’s F12 medium (1:1) (DMEM/F12) (Invitrogen,
Carlsbad, California) supplemented with 6% (vol/vol) heat-dena-
tured fetal bovine serum (Asahi Techno Glass, Tokyo, Japan), 2%
(vol/vol) human serum (ICN Biochemicals, Costa Mesa, California),
0.68 mM L-glutamine (Invitrogen), and recombinant human EGF (10
ng per mL) (Progen Biotechnik GmbH, Heidelberg, Germany) were
plated in 35, 60, or 100 mm diameter culture dishes (Becton Dic-
kinson, Tokyo, Japan) for 24 h to achieve complete cell adhesion.
Next, the cells were treated every 3 d with non-selective COX in-
hibitors, indomethacin and diclofenac (Sigma Chemical, St. Louis,
Missouri); a COX-2-specific inhibitor; NS-398 (Calbiochem-Nova-
biochem, San Diego, California); and ligand activators of PPARg,
15d-PGJ2 (Cayman Chemical, Ann Arbor, Michigan) and troglita-
zone (kindly provided by Sankyo, Tokyo, Japan), in the presence or
absence of non-selective CYP inhibitors, SKF-525A or methox-
salen (Sigma), in DMEM/F12 supplemented with heat-denatured
fetal bovine serum, human serum, and L-glutamine for up to 14 d.
In this series of experiments, hamster sebocytes were used at up
to the 3rd passage level.
Oil-red-O staining Cultured hamster sebocytes were washed
once with Ca2þ - and Mg2þ -free phosphate-buffered saline and
fixed with 4% (wt/vol) paraformaldehyde (Wako Pure Chemicals,
Osaka, Japan) diluted with Ca2þ - and Mg2þ -free phosphate-buff-
ered saline for 1 h at room temperature. The cells were washed
with distilled H2O and then stained with 0.3% (wt/vol) oil-red O
(Sigma) in isopropanol:distilled H2O (3:2, vol/vol) at 371C for
15 min. The stained cells were washed with distilled H2O, and then
viewed with a light microscope equipped with a digital camera
(Olympus Optical, Tokyo, Japan).
Histochemical staining Auricles of 5-wk-old male golden ham-
sters were topically treated everyday with 50 mL of 2% (wt/vol)
indomethacin in 95% (vol/vol) ethanol and 5% (wt/vol) glycerol, or
with the same volume of vehicle for 14 d. After the treatment, the
tissues were fixed with 4% (wt/vol) paraformaldehyde, embedded
in paraffin, and then their sections were subjected to Mayer’s
hematoxylin–eosin staining (Wako Pure Chemicals). After termi-
nating the staining, tissue secretions were washed with ethanol
and xylene, and then viewed with a light microscope equipped with
a digital camera. The animals had free access to food and water
according to the Guidelines of Experimental Animal Care issued by
the Prime Minister’s Office of Japan. The experimental protocol
was approved by the Committee of Animal Care and Use of Tokyo
University of Pharmacy and Life Science.
Quantitative analysis of intracellular lipids The lipid composi-
tion of extracts of intracellular lipids was analyzed by an automatic
TLC, Iatroscan (Iatron Laboratories, Tokyo, Japan) using authentic
tripalmitin, palmitic acid, cholesterol, cholesterol palmitate (Doo-
san Serdary Research Laboratories, Englewood Cliffs, New Jer-
sey), and palmityl palmitate (wax ester) (Nu-Chek-Prep, Elysian,
Minnesota) as described previously (Sato et al, 2001a). The
amounts of lipid components were also calculated using an inter-
nal control concomitantly performed using authentic cholesterol
acetate (2 mg) (Doosan Serdary Research Laboratories). Otherwise,
the sonicated-cell lysates were used to measure the level of in-
tracellular TG using Liquitech TG-II (Roche Diagnostics, Tokyo,
Japan) according to the manufacturer’s instructions. The amount of
TG was calculated using an authentic trioleinate-standard solution
(60 mg per mL). The intracellular DNA content was measured using
authentic salmon sperm DNA (6.25–100 mg per mL) and 3,5-di-
aminobenzoic acid dihydrochloride (Sigma) as described previ-
ously (Sato et al, 2001a).
DGAT activity Hamster sebocytes were homogenized in 20 mM
Tris-HCl (pH 7.6), 0.25 M sucrose, 2 mM MgCl2, and 50 mM KCl,
and then centrifuged at 12,000  g for 15 min at 41C. The har-
vested supernatants were further centrifuged at 105,000  g for 60
min at 41C. The precipitates were resuspended in 20 mM Tris-HCl
(pH 7.6), 0.15 M KCl, and 1 mM EDTA, and then centrifuged under
the same conditions. The resultant precipitates were resolved in
distilled H2O and then subjected to the measurement of DGAT
activity (Coleman and Bell, 1976). Briefly, aliquots (3 mg) of the
samples were incubated with 40 nM 1,2-dioleoyl glycerol (Cayman
Chemical), and 5 nM [14C]palmitoyl-CoA (Amersham Biosciences,
Tokyo, Japan) in 175 mM Tris-HCl (pH 7.6), 8 mM MgCl2, and 1%
(wt/vol) fatty-acid-free bovine serum albumin for 10 min at 371C.
The reaction was terminated by adding 2-propanol:heptane:dis-
tilled H2O (40:10:1; vol/vol/vol) solution. After adding heptane:dis-
870 IWATA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
tilled H2O (2:1; vol/vol) solution, the radioactivity of synthesized
14C-labeled TG in the extracted heptane layer was measured by a
liquid-scintillation counter. We note that the main component of the
heptane extraction on silica-gel 60 F254-coated TLC (Merck, Dar-
mstadt, Germany) by iodic visualization had the same relative flow
as that of authentic TG (2 mg per mL) (data not shown). In addition,
we confirmed that the radioactivity of synthesized 14C-labeled TG
decreased in the presence of 1 mM EDTA or 0.1% (wt/vol) Tween
20 (data not shown) as described previously (Coleman and Bell,
1976), suggesting that this assay is reliable for the measurement of
DGAT activity in vitro.
Enzyme immunoassay for PGE2, PGF2a, PGD2, and 15d-
PGJ2 Amounts of PGE2, PGF2a, PGD2, and 15d-PGJ2 in harvest-
ed culture media were measured using enzyme immunoassay kits
for PGE2, PGF2a, and PGD2 (Cayman Chemical), and for 15d-PGJ2
(Assay Designs, Ann Arbor, Michigan) according to the manufac-
turers’ instructions.
Western blot analysis for COX Cells and sebaceous glands were
homogenized in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl,
1% (wt/vol) NP-40, 0.1% (wt/vol) SDS, 1 mM EDTA, 10 mg per
mL leupeptin, and 1 mM phenylmethylsulfonyl fluoride, and then
subjected to sonication as described previously (Noguchi et al,
2003). After centrifugation at 8000  g for 15 min at 41C, proteins
(80 mg) in the resulting supernatant were subjected to SDS-polya-
crylamide gel electrophoresis using 10% (wt/vol) acrylamide gel,
and then electrotransferred onto a nitrocellulose membrane as
described previously (Sato et al, 2001b). The membranes were
reacted with rabbit anti-(human COX-1) or anti-(human COX-2)
antibody (Cayman Chemical), which was then complexed with
horseradish peroxidase-conjugated goat anti-(rabbit IgG)IgG (Si-
gma). Immunoreactive COXs were visualized with enhanced
chemiluminescence–Western blotting detection reagents (Amer-
sham Biosciences) according to the manufacturer’s instructions.
Statistical analysis Data are presented as the mean  standard
deviation, and were analyzed by a one-way analysis of variance
and by the Fisher test for multiple comparisons. A value of po0.05
was considered to indicate a statistically significant difference.
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